Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells
Despite significant advances in chemotherapy, the overall prognosis of hepatocellular carcinoma (HCC) remains extremely poor. HCC targeting strategies were combined with the tumor cell cytotoxicity of oncolytic viruses (OVs) to develop a more efficient and selective therapeutic system. OVs were coat...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-06-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/7/949 |
| _version_ | 1797528883089637376 |
|---|---|
| author | Mariangela Garofalo Federica Bellato Salvatore Magliocca Alessio Malfanti Lukasz Kuryk Beate Rinner Samuele Negro Stefano Salmaso Paolo Caliceti Francesca Mastrotto |
| author_facet | Mariangela Garofalo Federica Bellato Salvatore Magliocca Alessio Malfanti Lukasz Kuryk Beate Rinner Samuele Negro Stefano Salmaso Paolo Caliceti Francesca Mastrotto |
| author_sort | Mariangela Garofalo |
| collection | DOAJ |
| description | Despite significant advances in chemotherapy, the overall prognosis of hepatocellular carcinoma (HCC) remains extremely poor. HCC targeting strategies were combined with the tumor cell cytotoxicity of oncolytic viruses (OVs) to develop a more efficient and selective therapeutic system. OVs were coated with a polygalactosyl-<i>b</i>-agmatyl diblock copolymer (Gal<sub>32</sub>-<i>b</i>-Agm<sub>29</sub>), with high affinity for the asialoglycoprotein receptor (ASGPR) expressed on the liver cell surface, exploiting the electrostatic interaction of the positively charged agmatine block with the negatively charged adenoviral capsid surface. The polymer coating altered the viral particle diameter (from 192 to 287 nm) and zeta-potential (from –24.7 to 23.3 mV) while hiding the peculiar icosahedral symmetrical OV structure, as observed by TEM. Coated OVs showed high potential therapeutic value on the human hepatoma cell line HepG2 (cytotoxicity of 72.4% ± 4.96), expressing a high level of ASGPRs, while a lower effect was attained with ASPGR-negative A549 cell line (cytotoxicity of 54.4% ± 1.59). Conversely, naked OVs showed very similar effects in both tested cell lines. Gal<sub>32</sub>-<i>b</i>-Agm<sub>29</sub> OV coating enhanced the infectivity and immunogenic cell death program in HepG2 cells as compared to the naked OV. This strategy provides a rationale for future studies utilizing oncolytic viruses complexed with polymers toward effective treatment of hepatocellular carcinoma. |
| first_indexed | 2024-03-10T10:05:39Z |
| format | Article |
| id | doaj.art-85dac3c92dc54b66a806ce6be05d5078 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-10T10:05:39Z |
| publishDate | 2021-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-85dac3c92dc54b66a806ce6be05d50782023-11-22T01:36:05ZengMDPI AGPharmaceutics1999-49232021-06-0113794910.3390/pharmaceutics13070949Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma CellsMariangela Garofalo0Federica Bellato1Salvatore Magliocca2Alessio Malfanti3Lukasz Kuryk4Beate Rinner5Samuele Negro6Stefano Salmaso7Paolo Caliceti8Francesca Mastrotto9Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyUniversité Catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Avenue Mounier, 73 bte B1 73.12, 1200 Brussels, BelgiumDepartment of Virology, National Institute of Public Health—National Institute of Hygiene, Chocimska 24, 00-791 Warsaw, PolandDivision of Biomedical Research, Medical University of Graz, Roseggerweg 48, 8036 Graz, AustriaDepartment of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, ItalyDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyDespite significant advances in chemotherapy, the overall prognosis of hepatocellular carcinoma (HCC) remains extremely poor. HCC targeting strategies were combined with the tumor cell cytotoxicity of oncolytic viruses (OVs) to develop a more efficient and selective therapeutic system. OVs were coated with a polygalactosyl-<i>b</i>-agmatyl diblock copolymer (Gal<sub>32</sub>-<i>b</i>-Agm<sub>29</sub>), with high affinity for the asialoglycoprotein receptor (ASGPR) expressed on the liver cell surface, exploiting the electrostatic interaction of the positively charged agmatine block with the negatively charged adenoviral capsid surface. The polymer coating altered the viral particle diameter (from 192 to 287 nm) and zeta-potential (from –24.7 to 23.3 mV) while hiding the peculiar icosahedral symmetrical OV structure, as observed by TEM. Coated OVs showed high potential therapeutic value on the human hepatoma cell line HepG2 (cytotoxicity of 72.4% ± 4.96), expressing a high level of ASGPRs, while a lower effect was attained with ASPGR-negative A549 cell line (cytotoxicity of 54.4% ± 1.59). Conversely, naked OVs showed very similar effects in both tested cell lines. Gal<sub>32</sub>-<i>b</i>-Agm<sub>29</sub> OV coating enhanced the infectivity and immunogenic cell death program in HepG2 cells as compared to the naked OV. This strategy provides a rationale for future studies utilizing oncolytic viruses complexed with polymers toward effective treatment of hepatocellular carcinoma.https://www.mdpi.com/1999-4923/13/7/949oncolytic adenovirushepatocellular carcinomacationic glycopolymerstumor targetingcancer therapiesASGPR |
| spellingShingle | Mariangela Garofalo Federica Bellato Salvatore Magliocca Alessio Malfanti Lukasz Kuryk Beate Rinner Samuele Negro Stefano Salmaso Paolo Caliceti Francesca Mastrotto Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells Pharmaceutics oncolytic adenovirus hepatocellular carcinoma cationic glycopolymers tumor targeting cancer therapies ASGPR |
| title | Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells |
| title_full | Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells |
| title_fullStr | Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells |
| title_full_unstemmed | Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells |
| title_short | Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells |
| title_sort | polymer coated oncolytic adenovirus to selectively target hepatocellular carcinoma cells |
| topic | oncolytic adenovirus hepatocellular carcinoma cationic glycopolymers tumor targeting cancer therapies ASGPR |
| url | https://www.mdpi.com/1999-4923/13/7/949 |
| work_keys_str_mv | AT mariangelagarofalo polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT federicabellato polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT salvatoremagliocca polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT alessiomalfanti polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT lukaszkuryk polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT beaterinner polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT samuelenegro polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT stefanosalmaso polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT paolocaliceti polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells AT francescamastrotto polymercoatedoncolyticadenovirustoselectivelytargethepatocellularcarcinomacells |